The following text field will produce suggestions that follow it as you type.

Loading Inventory...

Barnes and Noble

Chronic Hepatitis C Virus: Advances in Treatment, Promise for the Future / Edition 1

Current price: $169.99
Chronic Hepatitis C Virus: Advances in Treatment, Promise for the Future / Edition 1
Chronic Hepatitis C Virus: Advances in Treatment, Promise for the Future / Edition 1

Barnes and Noble

Chronic Hepatitis C Virus: Advances in Treatment, Promise for the Future / Edition 1

Current price: $169.99
Loading Inventory...

Size: OS

Visit retailer's website
*Product Information may vary - to confirm product availability, pricing, and additional information please contact Barnes and Noble
Chronic Hepatitis C Virus: Lessons from the Past, Promise for the Future
documents the monumental advances that have been made in our understanding of chronic HCV during the past decade. The first section reviews the natural history of chronic HCV, how this virus can affect other organs in addition to the liver, and whether treating chronic HCV alters the natural history of this disease. Section 2 reviews the advances that have been made in the treatment of chronic HCV during the past decade with interferon based therapy. Separate chapters on response guided therapy and how to manage the adverse events associated with these medications provide the physician with the concepts required to more effectively treat chronic HCV now and in the future. As the genetics of virologic response have recently been elucidated, a chapter is devoted to helping the clinician understand how genes that modulate disease processes and their treatment are identified and utilized in clinical care. Section 3 deals with the future of HCV treatment and specific inhibitors of HCV. Specific chapters explain how targets for drugs are identified and how drugs are then developed and tested; how mutations of HCV develop and how anti-viral agents will affect this process; the most up to date data regarding the treatment of chronic HCV with peginterferon, ribavirin and anti-viral agents; and the potential to treat chronic HCV with just oral anti-viral agents and without peginterferon and ribavirin in the future. The final section of this book covers issues related to liver transplantation in patients with chronic HCV. Separate chapters review the natural history of chronic HCV in liver transplant recipients and the impact of utilizing HCV positive donors. The volume concludes with chapters that cover the treatment of chronic HCV both prior to and after liver transplantation with potent anti-viral agents.
is avaluable resource for all physicians caring for patients with chronic HCV.

More About Barnes and Noble at MarketFair Shoppes

Barnes & Noble does business -- big business -- by the book. As the #1 bookseller in the US, it operates about 720 Barnes & Noble superstores (selling books, music, movies, and gifts) throughout all 50 US states and Washington, DC. The stores are typically 10,000 to 60,000 sq. ft. and stock between 60,000 and 200,000 book titles. Many of its locations contain Starbucks cafes, as well as music departments that carry more than 30,000 titles.

Powered by Adeptmind